Gibby Wagner
Associate Corporate & Finance
-
Overview
-
Experience
-
Credentials
-
Insights and events
Gibby regularly advises on a broad range of corporate and securities matters, including mergers and acquisitions, public and private debt and equity offerings, and general corporate governance.
Gibby focuses her practice on business transactions, including mergers and acquisitions and capital markets transactions. She also advises on SEC disclosure, compliance, and corporate governance matters. Gibby has represented companies spanning a number of industries, particularly in the life sciences sector.
Prior to joining Hogan Lovells, she earned simultaneous J.D. and M.B.A. degrees from Villanova University, where she served as the vice president of the Corporate Law Society.
Representative experience
Marvell Technology Group (NASDAQ: MRVL) on its US$10bn acquisition of Inphi (NYSE: IPHI) in a cash-and-stock transaction.
Represented a leading developer and manufacturer of recombinant proteins in its US$1.85bn sale to a global supplier of scientific instrumentation, reagents, and consumables.
Represented a life sciences and health care contract manufacturing company in its sale to a leading manufacturer of consumer goods.
Represented EyePoint Pharmaceuticals Inc. in its US$115m underwritten public offering of equity securities through a syndicate of underwriters led by Cowen and Gugenheim Securities.
Credentials
- J.D., Villanova University School of Law, cum laude, 2019
- M.B.A., Villanova University, 2019
- B.A., Boston College, 2014
- Pennsylvania